Metformin and melatonin improve histopathological outcome of NMU-induced mammary tumors in rats.

Abstract

OBJECTIVE:

Numerous reports showed inhibition of carcinogenesis after metformin (MF) and melatonin (MEL) administration. However, most in vivo studies used standard diet type, with relatively low fat content. As increase in fat intake may have a considerable impact on malignant transformation, we evaluated the effects of these two substances in a model of mammary carcinogenesis in rats fed a high-fat diet (10%).

METHODS:

Mammary tumors were induced by N-methyl-N-nitrosourea (NMU) in female rats of sensitive Sprague-Dawley strain. MF was administered in a diet (0.2%), MEL was administered in drinking water (20 mg/L). The chemoprevention was initiated 12 days prior to tumor initiation, both substances were administered through the termination of the experiment on 16th week after carcinogen application. Analysis of basic parameters of tumor growth, histopathological profile, and serum IGF-1 level were performed together with immunohistochemical detection of Ki67 (proliferation marker) and caspase-3 and BCL-2 (apoptosis markers) in mammary cancer cells.

RESULTS:

Although neither tumor incidence nor frequency were changed after MF and/or MEL administration, MF and MEL decreased high-grade/low-grade (HG/LG) tumor ratio. MEL decreased proliferation in mammary cancer cells; positive correlations between histological grade and Ki67 expressions were found after single administration of both MF and MEL. Serum IGF-1 levels were reduced to the level of intact rats in all groups receiving chemoprevention.

CONCLUSIONS:

MF and MEL administration did not inhibit growth of NMU-induced mammary tumors in rats in a significant manner but both substances ameliorated tumor histopathological profile. Surprisingly, combined treatment had no such effect.

• Authors: Bianka Bojková, Karol Kajo, Peter Kubatka, Peter Solár, Martin Péč, Marián Adamkov
• Journal: Pathology, research and practice (Pathol Res Pract) Vol. 215 Issue 4 Pg. 722-729 (Apr 2019) ISSN: 1618-0631 [Electronic] Germany
• PMID: 30642742 (Publication Type: Journal Article)
• Copyright: Copyright © 2019 Elsevier GmbH. All rights reserved.

Chemical References

• Methylnitrosourea
• Metformin
• Melatonin

Topics

• Animals
• Cell Proliferation (drug effects)
• Diet, High-Fat
• Female
• Mammary Neoplasms, Experimental (chemically induced, drug therapy, pathology)
• Melatonin (pharmacology, therapeutic use)
• Metformin (pharmacology, therapeutic use)
• Methylnitrosourea
• Rats
• Rats, Sprague-Dawley